Clinical Practice of Haemoadsorption Combined with Haemodialysis in Maintenance Haemodialysis Patients with Kidney Failure: Chinese Expert Consensus

Despite advancements in dialysis technology, patients with kidney failure who are on maintenance haemodialysis (MHD) continue to experience high morbidity and mortality. Haemoadsorption combined with haemodialysis (HAHD) has emerged as a promising therapy to address these challenges. In light of the increasing adoption of HAHD in patients receiving MHD, there is a pressing need to demonstrate the safety and effectiveness of HAHD treatment. Consequently, a panel of Chinese experts developed a consensus on HAHD on the basis of the published literature and collective clinical experience. The consensus outlines six critical issues concerning HAHD treatment: patient population, contraindications, heparinization and priming procedures, prescription of HAHD, adjustment of medication dosages, and potential treatment-associated adverse events. After evaluation using a Delphi methodology, 19 statements achieved consensus (7 recommendations and 12 practice points). The overarching goal is to provide best-practice recommendations formulated by the HAHD consensus group to guide the use of haemoadsorption in MHD patients.